You are invited to learn and exchange on findings related to our strategic orientations and operational portfolio
Programme
09.30-10.30 AM (CET time) - Antibiotic resistance –presentation of 2 OR studies and panel discussion - Moderator: Amrish Baidjoe (MSF-OCB LuxOR/LSHTM)
Presenters: Géraldine Fisher (MSF OCB E-pool pharmacist), Angela Uyen (OCB Analysis Unit) & Anita Williams (MSF-OCB LuxOR/MEMU)
Panel: Ernestina Repetto (MSF-OCG), Angela Uyen (OCB Analyses Unit), Anita Williams (MSF-OCB LuxOR/MEMU), Mohamed Khalife (MSF-OCB/MEMU ABR Referent)
Recognizing antibiotic resistance as one of the major threats to global health and our operations, MSF is committed to combine proven strategies, innovation and new tools, training and advocacy to scale up our response to the challenge of antibiotic resistance in the contexts where we work. We aim to build operational models which are adapted to low resource settings, that improve the quality of care for patients, contribute to global microbial surveillance, undertake evidence based advocacy for the improved management and conservation of antibiotics. Several evidence gaps persist on contributing factors such as resistance patterns, overprescription of antibiotics, non-compliance to IPC practices and lack of access to diagnostics, that MSF will contribute filling through ongoing and future operational research.
10.30 - 11.00 AM: Morning Break (CET Time)
11.00 – 12.00 AM (CET Time) - Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic – presentation and panel discussion - Moderator: Tom Ellman (MSF-OCB SAMU)
Presenter: Dr Colin Pfaff (MSF-OCB MedCo Khayelitsha)
Panel: Hannah Spencer (MSF-OCB SAMU), Tom Decroo (Institute of Tropical Medicine), Marc Biot (MSF-OCB Director of Operations)
Often referred to as treatment of tuberculosis infection, WHO has recommended a number of tuberculosis preventive therapy regimens for individuals (including children and adolescents) at high risk, including those exposed to rifampicin-resistant forms of tuberculosis (RR-TB), and has recently expanded their tuberculosis preventive therapy recommendations to include exposed household contacts. The relevance of these recommendations seems even higher during the COVID-19 pandemic time, characterized by lower access to prompt TB diagnosis and treatment. MSF has been providing tuberculosis preventive therapy for children and adolescents exposed to RR-TB in households in Khayelitsha, South Africa, as part of a joint emergency response plan implemented with the National, Provincial, and City
Departments of Health in Cape Town.
12.00 – 12.30 AM (CET Time) - Relevance and importance of research agendas for MSF – presentation and discussion - Moderator: Amrish Baidjoe (MSF-OCB LuxOR/LSHTM) and Tom Ellman (MSF-OCB SAMU)